Medisafe has secured $30 million in Series C funding led by Sanofi Ventures to enhance its digital health platform aimed at improving medication adherence.
Information on the Target
Medisafe, an Israeli digital health startup, has announced the successful completion of a $30 million Series C funding round. This funding was spearheaded by Sanofi Ventures, the investment arm of the esteemed global pharmaceutical company Sanofi. Founded in 2012, Medisafe has successfully raised a total of $25 million prior to this round, and it currently employs around 50 people across Israel and the United States. The company is known for its innovative platform aimed at medication management, boasting over seven million registered users.
In 2020, Medisafe expanded its offerings with the introduction of Medisafe Care Connector, a feature designed to digitally connect patients with healthcare providers. This expansion is indicative of the company's commitment to enhancing patient care and improving medication adherence, which is critical in today’s healthcare landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Israel
The digital health industry in Israel is experiencing remarkable growth, fueled by advancements in technology and an increasing demand for remote healthcare solutions. The Covid-19 pandemic has accelerated this tren
Similar Deals
Harel Insurance & Finance, European Innovation Council (EIC) Fund → Omnix Medical
2025
Sanofi Ventures
invested in
Medisafe
in 2023
in a Other deal
Disclosed details
Transaction Size: $30M